ERT Merges with Bioclinica to Create Global Clinical Trial Endpoint Leader

Astorg Joins Nordic Capital and Novo Holdings in Recapitalization of ERT

October 21, 2019

Healthcare Services

Astorg will invest in eResearchTechnology, Inc. (ERT), joining existing owners Nordic Capital, Novo Holdings A/S and the ERT management team in a broadened ownership group. The investors will support continued development of ERT's clinical trial technology platform, expand operational capabilities, and pursue selective add-on acquisitions to drive future growth; financial terms were not disclosed.

MRO Acquires Clinetic

November 18, 2025

Healthcare Services

MRO has acquired Clinetic, an AI-driven patient recruitment management platform that integrates with provider EHRs to identify and enroll patients for clinical trials. MRO plans to incorporate Clinetic’s software across its clinical data platform (including the Q-Centrix Research Network) to expand recruitment capacity, streamline enrollment, and enhance research capabilities for hospitals, health systems, and life sciences sponsors.

Evestia Clinical Merges with Atlantic Research Group

July 15, 2025

Healthcare Services

Kester Capital-backed Evestia Clinical has merged with US-based Atlantic Research Group (ARG) to create a larger independent specialist CRO with dual headquarters in Letchworth, UK and Charlottesville, VA. The combination expands Evestia's US footprint and adds neurology and late-stage clinical trial capabilities while broadening therapeutic expertise across oncology, rare diseases, immunology and inflammation.

ERT Acquires APDM Wearable Technologies

June 10, 2020

Medical Devices

ERT, a global clinical endpoints data and technology company, has acquired APDM Wearable Technologies, a provider of medical-grade wearable sensors and digital biomarkers. The deal integrates APDM's Opal sensors and analytics with ERT's eCOA and clinical data platforms to expand objective endpoint measurement in movement disorder and CNS trials; financial terms were not disclosed.

Everest Clinical Research (Arlington) Acquires August Research

November 7, 2023

Healthcare Services

Everest Clinical Research, a portfolio company of Arlington Capital Partners, has acquired European contract research organization August Research. The deal expands Everest's European footprint and clinical trial (CTS) and pharmacovigilance (PV) capabilities across 14 countries; August's founders will remain with the business. Financial terms were not disclosed.

Everest Clinical Research Acquires Brightech International

December 2, 2022

Healthcare Services

Everest Clinical Research, a PE-backed full-service contract research organization, has acquired Brightech International, a specialist CRO focused on biostatistics, statistical programming, and clinical data management. The deal strengthens Everest's biometrics capabilities and global footprint, complementing its therapeutic strengths in Oncology, CNS, and Immunology.